Sudarshan Pharma IPO

Sudarshan Pharma IPO description - The company was established in 2008 as Sudarshan Specialty Chemsolve Private Limited and its name was changed to the current one in 2016. It markets pharmaceutical formulation & products in the Domestic and International markets through its own distribution network and sales force under its own brand. The company has a contract manufacturing agreement with four pharmaceutical companies. The company also supplies generic pharmaceutical formulation as – Make to order – for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports.

Sudarshan Pharma supplies Active Pharmaceutical Ingredients (APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets with a presence in 5 States. To develop its export business, the company is in the process of applying for 16 formulation registrations in countries like Ghana, Georgia, Cambodia, Myanmar, Nigeria, Kenya, Malaysia & MINA region.

The management is planning for business expansion by having its own state of the art manufacturing facility at Wada, near Mumbai, Maharashtra.

Sudarshan Pharma promoters – Mr Hemal V. Mehta & Mr Sachin V. Mehta
Sudarshan Pharma - Upcoming IPO details
Subscription Dates 12 - 17 June 2019
IPO Price band INR75 per share
Fresh issue 3,440,000 shares (INR25.80 crore)
Offer for sale Nil
Total IPO size 3,440,000 shares (INR25.80 crore)
Minimum bid (lot size) 1,600 shares
Face Value  INR10 per share
Retail Allocation 50%
Listing On NSE Emerge SME platform
Use of funds
  • To set up a dedicated manufacturing facility for Pharmaceutical Business - INR12.50 crore
  • Distribution and Warehousing Centre‘s & Purchase of Corporate Office - INR4.50 crore
  • Additional Working Capital - INR5.25 crore
  • General Corporate Expenses - INR2.80 crore
  • Issue Expenses - INR0.75 crore
Sudarshan Pharma's consolidated financial performance (in INR crore)
FY2016 FY2017 FY2018 6M FY2019
Total revenue 37.9 55.5 89.8 60.7
Total expenses 37.8 55.3 88.8 58.7
Profit after tax 0.09 0.16 0.74 1.46
Sudarshan Pharma Industries Contact Details

Sudarshan Pharma Industries Limited 
301, 3rd Floor, Aura Biplex
Above Kalyan Jewellers, S V Road
Borivali (West), Mumbai – 400 092

Phone: +91 22 242221111
Email: [email protected]
Website: www.sudarshanpharma.com

Sudarshan Pharma IPO Subscription Details
Day Subscription (no. of times)
Day 1 0.07
Day 2 0.14
Day 3 0.21
Day 4
Day 5
Sudarshan Pharma Valuation (For FY2018)

Earnings Per Share (EPS): INR2.90

Price/Earnings (P/E) ratio: 25.86

Return on Net Worth (RONW): 8.66%

Net Asset Value (NAV): INR18.10 per share

Registrar of Sudarshan Pharma IPO

Karvy Fintech Private Limited
Karvy Selenium Tower B, Plot 31-32,
Gachibowli, Nanakramguda,
Hyderabad – 500 032, Telangana

Phone: +91 40 6716 2222 
Fax:
 +91 40 2343 1551 
Email:
[email protected]
Website: www.karvyfintech.com

Sudarshan Pharma IPO Allotment Status

Sudarshan Pharma IPO allotment status will be available on Karvy website. Click on this link to get allotment status.

Listing performance of Sudarshan Pharma

IPO Opening Date: 12 June 2019

IPO Closing Date: 17 June 2019

Listing Date: To be updated

Listing Price on NSE SME: To be updated

Closing Price on NSE SME: To be updated

Sudarshan Pharma IPO
4 (80%) 16 vote[s]

One thought on “Sudarshan Pharma IPO

  • May 31, 2019 at 11:40 AM
    Permalink

    Strong financials backed by sound promoters. Worth taking a look.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *